EAM
OLMA icon

Erste Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Erste Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$510K Buy
+38,000
New +$846K ﹤0.01% 505

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Erste Asset Management's OLMA Position: Q1 2026 in Review

Erste Asset Management opened a new position in Olema Pharmaceuticals (OLMA) in Q1 2026: 38,000 shares worth $510K. The stake represents ﹤0.01% of the portfolio and ranks #505 among its holdings.

195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Erste Asset Management held 38,000 shares of Olema Pharmaceuticals worth $510K as of Q1 2026.
  • Olema Pharmaceuticals was a new Erste Asset Management position in Q1 2026.
  • Olema Pharmaceuticals made up ﹤0.01% of Erste Asset Management's portfolio in Q1 2026, its #505 holding.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Erste Asset Management's 13F filing for Q1 2026, filed 11 May 2026.